The Gulf Journal of Oncology Releases Highly Efficient Manuscripts in Issue 43, September 2023
State of Kuwait: – The Gulf Journal of Oncology (GJO), the official journal of the Gulf Federation for Cancer Control (GFFCC), is pleased to announce the publication of its latest issue, Issue 43, September 2023, now available in both digital and print formats.
In this issue, GJO proudly presents a selection of the most efficient and impactful manuscripts in the field of oncology. As part of our commitment to advancing cancer research and treatment, we have gathered original studies, case reports, and reviewed articles from esteemed authors and researchers worldwide.
What’s Inside Issue 43:
- Cutting-Edge Research: Discover the latest breakthroughs and innovations in the field of oncology.
- In-Depth Case Reports: Gain insights into rare and complex cases, providing valuable clinical knowledge.
- Comprehensive Reviews: Access comprehensive articles that critically analyze key topics in cancer research and treatment.
The Gulf Journal of Oncology, known for its dedication to excellence, is published thrice-annually, with issues released in January, May, and September each year. Our reach extends beyond the Gulf and Arab region, encompassing countries in South Asia, North Africa, Europe, and North America.
- PubMed and Medline Indexing: GJO has been indexed by PubMed and Medline Database since 2007, ensuring the global recognition and accessibility of our published content.
- Online Access: Readers can access GJO online through our website at http://www.gffcc.org/journal.
Request Your Hard Copy:
For those who prefer the tangible experience of a printed journal, hard copies of Issue 43, September 2023, are available upon request. We are delighted to offer delivery services through couriers or DHL, with shipping expenses to be covered by the recipients.
To request your hard copy, please contact us at firstname.lastname@example.org with your details and shipping preferences.
The Gulf Journal of Oncology remains committed to fostering collaboration, disseminating knowledge, and advancing the fight against cancer. We extend our sincere gratitude to all our contributors, readers, and partners for their continued support.